I look at The New England Journal of Medicine every week. I chose the word “look,” instead of “read,” because I just look through many of the articles about clinical studies, gleaning the basics of, for example: “CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma” (Nov. 1, 2018): I recognize rituximab as an antibody-type …